APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pathogen Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pathogen Testing Market Outlook and Growth Opportunities 2026

29 December 2025191 pages

Choose your research edition.

Industry ResearchPathogen Testing Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Pathogen Testing Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pathogen Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pathogen Testing Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pathogen Testing Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Global Pathogen Testing includes SGS SA, Eurofins Scientific, Institut Mérieux, etc. Global top three companies hold a share over 40%. Europe is the largest market, with a share about 26%, followed by North America and China with the share about 21% and 17%.

This report provides an overview of the global Pathogen Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pathogen Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

Read the full market overview

The report also presents Pathogen Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pathogen Testing market.

Pathogen Testing Segment by Company

SGS SA

Eurofins Scientific

Institut Mérieux

ALS Limited

Charles River

Intertek Group

Symbio Laboratories

TUV Nord

FoodChain ID Group

AsureQuality

Microbac Laboratories

Guangdong IQTC

IFP Institut für Produktqualität GmbH

Vimta Labs

Pathogen Testing Segment by Type

PCR

LAMP

Pathogen Testing Segment by Application

Food Industry

Laboratory

Others

Pathogen Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pathogen Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pathogen Testing key companies, revenue, market share, and recent developments.

3. To split the Pathogen Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pathogen Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pathogen Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Pathogen Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathogen Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pathogen Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathogen Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pathogen Testing industry.

Chapter 3: Detailed analysis of Pathogen Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pathogen Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pathogen Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pathogen Testing Industry Trends Table 2. Pathogen Testing Industry Drivers Table 3. Pathogen Testing Industry Opportunities and Challenges Table 4. Pathogen Testing Industry Restraints Table 5. Global Pathogen Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pathogen Testing Revenue Share by Company (2021-2026) Table 7. Global Pathogen Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pathogen Testing Key Company Manufacturing Base & Headquarters Table 9. Global Pathogen Testing Company, Product Type & Application Table 10. Global Pathogen Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pathogen Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of PCR Table 15. Significant Companies of LAMP Table 16. Global Pathogen Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pathogen Testing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pathogen Testing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pathogen Testing Sales Value Share by Type (2021-2026) Table 20. Global Pathogen Testing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Food Industry Table 22. Significant Companies of Laboratory Table 23. Significant Companies of Others Table 24. Global Pathogen Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pathogen Testing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Pathogen Testing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Pathogen Testing Sales Value Share by Application (2021-2026) Table 28. Global Pathogen Testing Sales Value Share by Application (2027-2032) Table 29. Global Pathogen Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pathogen Testing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Pathogen Testing Sales Value Share by Region (2021-2026) Table 32. Global Pathogen Testing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Pathogen Testing Sales Value Share by Region (2027-2032) Table 34. Global Pathogen Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pathogen Testing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Pathogen Testing Sales Value Market Share by Country (2021-2026) Table 37. Global Pathogen Testing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Pathogen Testing Sales Value Market Share by Country (2027-2032) Table 39. SGS SA Company Information Table 40. SGS SA Business Overview Table 41. SGS SA Pathogen Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. SGS SA Pathogen Testing Product Portfolio Table 43. SGS SA Recent Development Table 44. Eurofins Scientific Company Information Table 45. Eurofins Scientific Business Overview Table 46. Eurofins Scientific Pathogen Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Eurofins Scientific Pathogen Testing Product Portfolio Table 48. Eurofins Scientific Recent Development Table 49. Institut Mérieux Company Information Table 50. Institut Mérieux Business Overview Table 51. Institut Mérieux Pathogen Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Institut Mérieux Pathogen Testing Product Portfolio Table 53. Institut Mérieux Recent Development Table 54. ALS Limited Company Information Table 55. ALS Limited Business Overview Table 56. ALS Limited Pathogen Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. ALS Limited Pathogen Testing Product Portfolio Table 58. ALS Limited Recent Development Table 59. Charles River Company Information Table 60. Charles River Business Overview Table 61. Charles River Pathogen Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Charles River Pathogen Testing Product Portfolio Table 63. Charles River Recent Development Table 64. Intertek Group Company Information Table 65. Intertek Group Business Overview Table 66. Intertek Group Pathogen Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Intertek Group Pathogen Testing Product Portfolio Table 68. Intertek Group Recent Development Table 69. Symbio Laboratories Company Information Table 70. Symbio Laboratories Business Overview Table 71. Symbio Laboratories Pathogen Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Symbio Laboratories Pathogen Testing Product Portfolio Table 73. Symbio Laboratories Recent Development Table 74. TUV Nord Company Information Table 75. TUV Nord Business Overview Table 76. TUV Nord Pathogen Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. TUV Nord Pathogen Testing Product Portfolio Table 78. TUV Nord Recent Development Table 79. FoodChain ID Group Company Information Table 80. FoodChain ID Group Business Overview Table 81. FoodChain ID Group Pathogen Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. FoodChain ID Group Pathogen Testing Product Portfolio Table 83. FoodChain ID Group Recent Development Table 84. AsureQuality Company Information Table 85. AsureQuality Business Overview Table 86. AsureQuality Pathogen Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. AsureQuality Pathogen Testing Product Portfolio Table 88. AsureQuality Recent Development Table 89. Microbac Laboratories Company Information Table 90. Microbac Laboratories Business Overview Table 91. Microbac Laboratories Pathogen Testing Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 92. Microbac Laboratories Pathogen Testing Product Portfolio Table 93. Microbac Laboratories Recent Development Table 94. Guangdong IQTC Company Information Table 95. Guangdong IQTC Business Overview Table 96. Guangdong IQTC Pathogen Testing Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 97. Guangdong IQTC Pathogen Testing Product Portfolio Table 98. Guangdong IQTC Recent Development Table 99. IFP Institut für Produktqualität GmbH Company Information Table 100. IFP Institut für Produktqualität GmbH Business Overview Table 101. IFP Institut für Produktqualität GmbH Pathogen Testing Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 102. IFP Institut für Produktqualität GmbH Pathogen Testing Product Portfolio Table 103. IFP Institut für Produktqualität GmbH Recent Development Table 104. Vimta Labs Company Information Table 105. Vimta Labs Business Overview Table 106. Vimta Labs Pathogen Testing Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 107. Vimta Labs Pathogen Testing Product Portfolio Table 108. Vimta Labs Recent Development Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Pathogen Testing Product Image Figure 2. Global Pathogen Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pathogen Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Pathogen Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. PCR Image Figure 8. LAMP Image Figure 9. Global Pathogen Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pathogen Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pathogen Testing Sales Value Share by Type (2021-2032) Figure 12. Food Industry Image Figure 13. Laboratory Image Figure 14. Others Image Figure 15. Global Pathogen Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pathogen Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pathogen Testing Sales Value Share by Application (2021-2032) Figure 18. Global Pathogen Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Pathogen Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Pathogen Testing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Pathogen Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Pathogen Testing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Pathogen Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Pathogen Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Pathogen Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Pathogen Testing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Pathogen Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Pathogen Testing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Pathogen Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Pathogen Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Pathogen Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Pathogen Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • PCR
  • LAMP
Applications
  • Food Industry
  • Laboratory
  • Others
Companies covered
  • SGS SA
  • Eurofins Scientific
  • Institut Mérieux
  • ALS Limited
  • Charles River
  • Intertek Group
  • Symbio Laboratories
  • TUV Nord
  • FoodChain ID Group
  • AsureQuality
  • Microbac Laboratories
  • Guangdong IQTC
  • IFP Institut für Produktqualität GmbH
  • Vimta Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pathogen Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pathogen Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pathogen Testing Market Dynamics
  1. 2.1 Pathogen Testing Industry Trends
  2. 2.2 Pathogen Testing Industry Drivers
  3. 2.3 Pathogen Testing Industry Opportunities and Challenges
  4. 2.4 Pathogen Testing Industry Restraints
3 Pathogen Testing Market by Company
  1. 3.1 Global Pathogen Testing Company Revenue Ranking in 2025
  2. 3.2 Global Pathogen Testing Revenue by Company (2021-2026)
  3. 3.3 Global Pathogen Testing Company Ranking (2024-2026)
  4. 3.4 Global Pathogen Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Pathogen Testing Company Product Type and Application
  6. 3.6 Global Pathogen Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pathogen Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pathogen Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pathogen Testing Market by Type
  1. 4.1 Pathogen Testing Type Introduction
  2. 4.1.1 PCR
  3. 4.1.2 LAMP
  4. 4.2 Global Pathogen Testing Sales Value by Type
  5. 4.2.1 Global Pathogen Testing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pathogen Testing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pathogen Testing Sales Value Share by Type (2021-2032)
5 Pathogen Testing Market by Application
  1. 5.1 Pathogen Testing Application Introduction
  2. 5.1.1 Food Industry
  3. 5.1.2 Laboratory
  4. 5.1.3 Others
  5. 5.2 Global Pathogen Testing Sales Value by Application
  6. 5.2.1 Global Pathogen Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pathogen Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pathogen Testing Sales Value Share by Application (2021-2032)
6 Pathogen Testing Regional Value Analysis
  1. 6.1 Global Pathogen Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pathogen Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pathogen Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pathogen Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pathogen Testing Sales Value (2021-2032)
  7. 6.3.2 North America Pathogen Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pathogen Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Pathogen Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pathogen Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pathogen Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pathogen Testing Sales Value (2021-2032)
  16. 6.6.2 South America Pathogen Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pathogen Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pathogen Testing Sales Value Share by Country, 2025 VS 2032
7 Pathogen Testing Country-level Value Analysis
  1. 7.1 Global Pathogen Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pathogen Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pathogen Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pathogen Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pathogen Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pathogen Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pathogen Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pathogen Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pathogen Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pathogen Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pathogen Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pathogen Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pathogen Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pathogen Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pathogen Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pathogen Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pathogen Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pathogen Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pathogen Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pathogen Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pathogen Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pathogen Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pathogen Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pathogen Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pathogen Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pathogen Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pathogen Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pathogen Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pathogen Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pathogen Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pathogen Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pathogen Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pathogen Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pathogen Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pathogen Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 SGS SA
  2. 8.1.1 SGS SA Company Information
  3. 8.1.2 SGS SA Business Overview
  4. 8.1.3 SGS SA Pathogen Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 SGS SA Pathogen Testing Product Portfolio
  6. 8.1.5 SGS SA Recent Developments
  7. 8.2 Eurofins Scientific
  8. 8.2.1 Eurofins Scientific Company Information
  9. 8.2.2 Eurofins Scientific Business Overview
  10. 8.2.3 Eurofins Scientific Pathogen Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eurofins Scientific Pathogen Testing Product Portfolio
  12. 8.2.5 Eurofins Scientific Recent Developments
  13. 8.3 Institut Mérieux
  14. 8.3.1 Institut Mérieux Company Information
  15. 8.3.2 Institut Mérieux Business Overview
  16. 8.3.3 Institut Mérieux Pathogen Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Institut Mérieux Pathogen Testing Product Portfolio
  18. 8.3.5 Institut Mérieux Recent Developments
  19. 8.4 ALS Limited
  20. 8.4.1 ALS Limited Company Information
  21. 8.4.2 ALS Limited Business Overview
  22. 8.4.3 ALS Limited Pathogen Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ALS Limited Pathogen Testing Product Portfolio
  24. 8.4.5 ALS Limited Recent Developments
  25. 8.5 Charles River
  26. 8.5.1 Charles River Company Information
  27. 8.5.2 Charles River Business Overview
  28. 8.5.3 Charles River Pathogen Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Charles River Pathogen Testing Product Portfolio
  30. 8.5.5 Charles River Recent Developments
  31. 8.6 Intertek Group
  32. 8.6.1 Intertek Group Company Information
  33. 8.6.2 Intertek Group Business Overview
  34. 8.6.3 Intertek Group Pathogen Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Intertek Group Pathogen Testing Product Portfolio
  36. 8.6.5 Intertek Group Recent Developments
  37. 8.7 Symbio Laboratories
  38. 8.7.1 Symbio Laboratories Company Information
  39. 8.7.2 Symbio Laboratories Business Overview
  40. 8.7.3 Symbio Laboratories Pathogen Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Symbio Laboratories Pathogen Testing Product Portfolio
  42. 8.7.5 Symbio Laboratories Recent Developments
  43. 8.8 TUV Nord
  44. 8.8.1 TUV Nord Company Information
  45. 8.8.2 TUV Nord Business Overview
  46. 8.8.3 TUV Nord Pathogen Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 TUV Nord Pathogen Testing Product Portfolio
  48. 8.8.5 TUV Nord Recent Developments
  49. 8.9 FoodChain ID Group
  50. 8.9.1 FoodChain ID Group Company Information
  51. 8.9.2 FoodChain ID Group Business Overview
  52. 8.9.3 FoodChain ID Group Pathogen Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 FoodChain ID Group Pathogen Testing Product Portfolio
  54. 8.9.5 FoodChain ID Group Recent Developments
  55. 8.10 AsureQuality
  56. 8.10.1 AsureQuality Company Information
  57. 8.10.2 AsureQuality Business Overview
  58. 8.10.3 AsureQuality Pathogen Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AsureQuality Pathogen Testing Product Portfolio
  60. 8.10.5 AsureQuality Recent Developments
  61. 8.11 Microbac Laboratories
  62. 8.11.1 Microbac Laboratories Company Information
  63. 8.11.2 Microbac Laboratories Business Overview
  64. 8.11.3 Microbac Laboratories Pathogen Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Microbac Laboratories Pathogen Testing Product Portfolio
  66. 8.11.5 Microbac Laboratories Recent Developments
  67. 8.12 Guangdong IQTC
  68. 8.12.1 Guangdong IQTC Company Information
  69. 8.12.2 Guangdong IQTC Business Overview
  70. 8.12.3 Guangdong IQTC Pathogen Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Guangdong IQTC Pathogen Testing Product Portfolio
  72. 8.12.5 Guangdong IQTC Recent Developments
  73. 8.13 IFP Institut für Produktqualität GmbH
  74. 8.13.1 IFP Institut für Produktqualität GmbH Company Information
  75. 8.13.2 IFP Institut für Produktqualität GmbH Business Overview
  76. 8.13.3 IFP Institut für Produktqualität GmbH Pathogen Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 IFP Institut für Produktqualität GmbH Pathogen Testing Product Portfolio
  78. 8.13.5 IFP Institut für Produktqualität GmbH Recent Developments
  79. 8.14 Vimta Labs
  80. 8.14.1 Vimta Labs Company Information
  81. 8.14.2 Vimta Labs Business Overview
  82. 8.14.3 Vimta Labs Pathogen Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Vimta Labs Pathogen Testing Product Portfolio
  84. 8.14.5 Vimta Labs Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst